
"Fund Professional Buyer" Public FOF Increases Holdings in Rare Earths and Innovative Drugs
With the release of the semi-annual reports of funds, the adjustment strategies of public FOFs, as "professional fund buyers," are more clearly presented to investors. Overall, public FOFs that achieved double growth in performance and scale in the first half of this year still recognize the attractiveness of equity assets and the structural characteristics of the market, and will continue to capture market opportunities during rotations. Specifically, high-performing FOF products remain optimistic and heavily invested in sectors such as rare earths, innovative pharmaceuticals, technology, and gold, while executing rebalancing strategies for certain sectors that have seen excessive short-term gains. Some fund managers have already begun to position themselves on the left side of the consumption sector, striving to accurately "place" themselves at the industry turning point. (Shanghai Securities News)

